Hypodontia or selective tooth agenesis Market Trends, Technology Enhancements and Growth Research 2019
Hypodontia
or selective tooth agenesis is the failure to form one or more teeth during
the developmental period. 2.6%–11% of the population across the globe suffers
from this condition. The exact cause of the condition remains unknown.
Increasing number of patients suffering from hypodontia drives the growth of
the market. Additionally, increasing prevalence of different dental diseases
have increased the demand for different treatments and boosted the growth of
the market. During last decade, a number of different treatments and diagnostic
devices were introduced to improve the prognosis of the condition. Well
developed technology has supported the growth of the market in this region,
however, high cost of the treatment may slow the market growth.
The global
hypodontia market is expected to grow at a CAGR of 6.2% during the forecast
period 2017-2023.
Hypodontia or selective tooth agenesis Market Regional Analysis:
The Americas
dominate the global hypodontia market owing to a large patient population,
strong government support for research & development, and high healthcare
spending. Additionally, increasing awareness has fuelled the growth of the
market.
Europe is the
second leading global hypodontia market which is followed by Asia Pacific which
is the fastest growing market for hypodontia.
Asia Pacific
hypodontia market is majorly driven by India, and China owing to a huge patient
pool, presence of huge opportunity for the market development and continuously
developing healthcare sector.
Browse Complete Premium Report Details at: https://www.marketresearchfuture.com/reports/hypodontia-market-5044
The Middle East
and Africa contribute the least in the growth of global hypodontia market.
Among the Middle East and Africa, the Middle East dominates the market of which
the UAE, Saudi Arabia, and Kuwait are expected to be the major contributors.
However, Africa holds the least share of the
global market due to limited availability of medical facilities and poor
economic condition. However, expected growth of the African
Hypodontia Market Key Players:
The key players
for the global hypodontia market are Patterson
Dental (U.S.), Henry Schein (U.S.), Dentsply Sirona (U.S.), 3M (U.S.), Pfizer
(U.S), Bayer AG (Germany), Straumann (Switzerland), Danaher Corporation
(Switzerland), PLANMECA OY (Finland), Carestream Health, Inc. (U.S), Biolase Inc (U.S), KERR Corporation (U.S), GC
orthodontics (Germany),, and American Orthodontics (U.S).
Comments
Post a Comment